コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ration and decreased the abundance of c-type cytochromes.
2 es the covalent attachment of heme to c-type cytochromes.
3 microscopy, to understand the involvement of cytochromes and other possible electron-mediating specie
4 es, showed higher activity of peroxidase and cytochrome, and gave largest removal of OMPs (removal of
5 o investigating the quantity and function of cytochromes, as well as the emergence of Fe-containing p
6 with PSII intermediate complexes containing cytochrome b (559) Complementation of the Chlamydomonas
7 tein, we similarly modified Escherichia coli cytochrome b (562) and the resulting protein behaves in
9 tutively high CEF through the associated PSI-cytochrome b (6) f supercomplex to support robust growth
10 nes cytochrome c oxidase subunit I (COI) and Cytochrome b as well as in the nuclear internal transcri
13 transport chain composed of NADH (or NADPH), cytochrome b(5) reductase (b(5)R), and cytochrome b(5) (
14 in and methemoglobin (MetHb) concentrations, cytochrome b(5) reductase (CYB5R) enzyme activities, gen
15 s oxidized and ring-opened by enzymes in the cytochrome b(561) and gluconolactonase families, respect
16 e high-resolution melting profiles from COI, cytochrome b, and 16S ribosomal RNA gene PCR products.
18 ly demethylates m6A of targeted mRNA such as cytochrome b5 form A (CYB5A) to increase its mRNA stabil
19 and the reducing systems, cytochrome b5 (B5)/cytochrome b5 reductase (B5R) and cytochrome P450 reduct
23 piration and bioenergetics predominantly via cytochrome bd oxidase, and that H(2)S reverses *NO-media
24 complexes (fox, sox, dox and a new putative cytochrome bd) are prevalent in many species (even facul
25 not menaquinone and demethylmenaquinone) and cytochrome bd-I (but not cytochromes bo(3) and bd-II) al
26 rmined the structure of the Escherichia coli cytochrome bd-I oxidase by single-particle cryo-electron
27 ed that in Escherichia coli the component of cytochrome bd-I terminal oxidase, the CydDC complex, shu
29 cryptic appBCX genes, predicted to encode a cytochrome bd-II oxidase, conferred a fitness advantage
31 hylmenaquinone) and cytochrome bd-I (but not cytochromes bo(3) and bd-II) also had completely abolish
32 ed the effects of heme loss on mitochondrial cytochromes by knocking down cytochrome c/c (1) heme lya
33 state abundances of both c-type cytochromes, cytochrome c (1) and cytochrome c The observed reduction
40 the adsorption behavior of the redox protein cytochrome c (Cyt-C) onto different interfaces, namely,
41 of mitochondrial permeability and release of cytochrome c (CytC) and apoptosis-inducing factor (AIF)
42 s circumvented by deleting the gene encoding cytochrome c (M) (CytM), a cryptic c-type heme protein w
43 nificantly lower ROS, cleaved caspase-3, and cytochrome c activities, leading to reduced spinal cord
45 Furthermore, translocation of mitochondrial cytochrome C and AIF was significantly alleviated in the
46 tive neurons, translocation of mitochondrial cytochrome C and apoptosis inducing factor (AIF), LC3B-p
47 ed minority MOMP noted by minimal release of cytochrome C and limited caspase 3 activation, which res
52 led device (CCD) detector after digesting of cytochrome c by immobilized trypsin enzymes on NAA-NH(2)
54 rt via an Hmc complex (high-molecular-weight cytochrome c encoded by dvu0531-dvu0536) and the Fe-only
56 ns that contain multiple heme groups (diheme cytochrome c from Rhodobacter sphaeroides and Desulfovib
60 ted to the mitochondria's ability to release cytochrome c into the cytosol, which triggers the apopto
62 sensing principle of proposed IRS sensor to cytochrome c is based on a change in the intensity of th
64 We have reported that once in the cytosol, cytochrome c is targeted for degradation by the E3 ligas
66 to the limited compatibility of the E. coli cytochrome c maturation (Ccm) systems with MR-1 cytochro
70 f a soluble heme lyase from an organism with cytochrome c maturation system III could functionally co
74 Here, we identify the proposed cbb (3)-type cytochrome c oxidase (cbb (3)-Cox) assembly factor CcoG
75 o hemoglobin and by inhibiting mitochondrial cytochrome c oxidase (CcO), thereby decreasing oxygen de
79 dendritic mitochondria and histochemistry of cytochrome c oxidase (CO) activity were examined in pre-
81 llar cristae was associated with the gain of cytochrome c oxidase (COX) function, and the COX subunit
82 ng cox10 gene encoding an assembly factor of cytochrome c oxidase (COX) specifically in mouse ECs, pr
83 his prediction measuring oxidation states of cytochrome c oxidase (oxCCO), an intracellular marker of
84 enase, pyruvate kinase, creatine kinase, and cytochrome c oxidase activities, and increased myoglobin
85 iron-sulfur assembly proteins)1/2 and COX10 (cytochrome c oxidase assembly protein-10), indicating en
86 he matrix side into the inner membrane while Cytochrome c oxidase assembly protein18 (Cox18/Oxa2) is
87 ression of key mitochondrial genes including cytochrome C oxidase copper chaperone (COX17) and ATP Sy
89 cluding impaired energy generation caused by cytochrome c oxidase dysfunction in the mitochondria.
91 , extracted DNA and sequenced mitochondrial (cytochrome c oxidase I [mtCOI]) and nuclear (small subun
92 tochondrial function that directly activates cytochrome c oxidase in the mitochondria and functions i
95 Complex III's Rieske Fe-S center and COX4i2 [cytochrome c oxidase subunit 4 isoform 2] in Complex IV)
96 in fragments of the mitochondrial (mt) genes cytochrome c oxidase subunit I (COI) and Cytochrome b as
97 EPAS1, and the nuclear-encoded mitochondrial cytochrome c oxidase subunit, COX4I2, in glomus cell sen
100 gly, yeast, mouse liver, and isolated bovine cytochrome c oxidase were directly inhibited by the drug
101 biopsies, cocoa improved mitochondrial COX (cytochrome c oxidase) activity (P=0.013), increased capi
109 ned in a structurally nonhomologous protein, cytochrome c peroxidase (CcP), by only two mutations (Cu
111 eme enzyme that is a member of the bacterial cytochrome c peroxidase superfamily, capable of generati
112 (p.Tyr314Ser) in the mitochondrial ubiquinol-cytochrome c reductase core protein 1 (UQCRC1) gene, whi
114 ter assembly and newly synthesized ubiquinol-cytochrome c reductase Rieske iron-sulfur polypeptide 1
116 totic signalling downstream of MOMP involves cytochrome c release from mitochondria and subsequent ca
118 d functionally uncouples BAX clustering from cytochrome c release, while knockdown of the Rab5 exchan
121 d via comet assay, CyQuant, annexin V, JC-1, cytochrome C subcellular localization, caspase 3 activat
123 oth c-type cytochromes, cytochrome c (1) and cytochrome c The observed reduction in the steady-state
126 hat oxidative alphaSyn aggregation scavenges cytochrome c's activity into the formation of amorphous,
127 ic bacterium Rhodobacter sphaeroides lacking cytochrome c(2) as natural electron donor to P(+) (mutan
129 ns (i.e., myoglobin, carbonic anhydrase, and cytochrome c) could be analyzed by SEC-ESI-MS using diff
131 the presence of reactive oxygen species and cytochrome c, a proapoptotic peroxidase that is released
136 usion rates of 6 Hz are used for analysis of cytochrome c, on a DTIMS Q-TOF similar rates were obtain
138 he dissociated heme to the protein moiety in cytochrome c, which we assign to the presence of covalen
139 yl arachidonoyl-phospholipids or through the cytochrome c-catalyzed oxidative hydrolysis of the vinyl
146 n mitochondrial cytochromes by knocking down cytochrome c/c (1) heme lyase 1 (TgCCHL1), a mitochondri
148 enes changed (increased transcriptional Bax, cytochrome-c and Apaf-1 and downregulated Bcl-2), wherea
151 plex composed of class I and class II c-type cytochromes called NaxLS, which has distinctive biochemi
152 alline STC with a cross-section of about 100 cytochromes could support the anaerobic respiration of a
153 e assessment of the effect in representative cytochromes (CYP3A4 and CYP2D6) demonstrated insignifica
154 or determining the mean distance between the cytochrome (CYT) and flavodehydrogenase (DH) domains of
155 n the steady-state abundances of both c-type cytochromes, cytochrome c (1) and cytochrome c The obser
158 m oxidation by O(2), as compared to those in cytochromes in solution, potentially allowing for effici
159 Among the most highly abundant of these cytochromes is a unique heterodimeric complex composed o
160 anaerobe, expresses a large number of c-type cytochromes, many of which function as anaerobic reducta
161 ediate redirection of electron flow from the cytochrome-mediated pathway to an alternative oxidase (A
162 lated biomolecular wire possessing a 10-heme cytochrome, MtrA, insulated from the membrane lipidic en
163 ate connection with an extracellular 10-heme cytochrome, MtrC, which presents its hemes across a larg
164 re for lower jaw skin surface was developed, cytochrome oxidase (CO) was used to label flattened-cut
165 We studied the time course of changes of cytochrome oxidase (CytOx) blob spatial density and blob
166 ue relies on sequencing of the mitochondrial cytochrome oxidase I (COI) 'barcode' gene, which remains
169 educed Thermus thermophilus ba(3) (Tt ba(3)) cytochrome oxidase revealed that O(2) binding was slowed
170 logical, and tracing studies suggest that V2 cytochrome oxidase stripes participate in functionally d
171 stituted with an active proton-translocating cytochrome oxidase, ATP synthesis readily occurred at th
173 ay, thereby circumventing the time-dependent cytochrome P (CYP) 450 inhibition observed with the C6-C
174 Directed evolution of genetically encoded cytochrome P411 enzymes (P450s whose Cys axial ligand to
175 onstrated with libraries of randomly mutated cytochrome P411 variants to identify improved catalysts
176 xial ligand has been substituted for serine (cytochrome P411), are fully genetically encoded and prod
179 chlorinated biphenyls (PCBs) is initiated by cytochrome P450 (CYP) enzymes and includes PCB oxidation
180 Toxicokinetic interactions with catabolic cytochrome P450 (CYP) enzymes can inhibit chemical elimi
185 ere we report on a terpene synthase (DdTPS8)-cytochrome P450 (CYP521A1) gene cluster that produces a
186 cient in flavodiiron proteins (FLVs) or in a cytochrome p450 (CYP55), we show that FLVs contribute to
189 ple organs and selected supersomes of single cytochrome P450 (cyt P450) enzymes on the magnetic beads
190 usion enzyme comprising two major domains: a cytochrome P450 (heme-binding) catalytic domain and a NA
200 /central zones during embryogenesis requires Cytochrome P450 26b1 (Cyp26b1)-mediated degradation of r
204 unds was also tested for metabolism by human cytochrome P450 3A4 (CYP3A4) and human aldehyde oxidase
206 de novo donor-specific antibody development, cytochrome P450 3A5 genotype, pregraft sensitization, mo
207 model, based on 666 patients with available cytochrome P450 3A5 genotypes, the effect of the C/D rat
208 Efavirenz (EFV) is an anti-HIV drug, and cytochrome P450 46A1 (CYP46A1) is the major brain choles
214 rformance (i.e. urea and albumin production, cytochrome P450 activity and induction studies) of the p
215 compared with static organoid cultures, and cytochrome p450 activity reached levels equivalent to he
217 ecretion of albumin and apolipoprotein B and cytochrome P450 activity; cholangiocytes were functional
221 Here, we report the characterization of the cytochrome P450 enzyme BotCYP from a bottromycin biosynt
222 Screening of a 48-variant library of the cytochrome P450 enzyme CYP102A1 (P450BM3), followed by t
225 ithelium (RPE), TH regulates expression of a cytochrome P450 enzyme, cyp27c1, that converts vitamin A
226 oxyresorufin-O-deethylase (EROD) activity of cytochrome P450 enzymes and continuous accumulation of f
229 Sterol 14alpha-demethylases (CYP51) are the cytochrome P450 enzymes required for biosynthesis of ste
231 oat transcriptome data to identify candidate cytochrome P450 enzymes that may catalyse C-21beta oxida
232 report a biocatalytic platform of engineered cytochrome P450 enzymes to carry out efficient cycloprop
233 ree kratom alkaloids tested inhibited select cytochrome P450 enzymes, suggesting a potential risk for
239 e polymorphism (SNP) rs7175922 in aromatase (cytochrome P450 family 19 subfamily A member 1 [CYP19A1]
240 e previously reported that overexpression of cytochrome P450 family 24 subfamily A member 1 (CYP24A1)
246 an isoform-specific probe for CYP3A4, a key cytochrome P450 isoform responsible for the oxidation of
247 ,18(S)-Epoxyeicosatetraenoic acid (EEQ) is a cytochrome P450 metabolite of eicosapentaenoic acid (EPA
248 orest (AUC = 0.83 [0.69, 0.96]), followed by cytochrome p450 metabolites using adaptive elastic-net (
252 Cinnamate 4-hydroxylase (C4H; CYP73A) is a cytochrome P450 monooxygenase associated externally with
257 Direct epoxidation of aromatic nuclei by cytochrome P450 monooxygenases is one of the major metab
259 0.05) following oral THC administration for cytochrome P450 oxidoreductase (Por), involved in toxin
261 of the mice treated with OCA, the levels of cytochrome P450 potentially involved in VPA metabolism w
262 selectivity versus other PDE enzymes, clean cytochrome P450 profile, in vivo target occupancy, and p
264 (heme-binding) catalytic domain and a NADPH-cytochrome P450 reductase (CPR) domain containing FAD an
265 me b5 (B5)/cytochrome b5 reductase (B5R) and cytochrome P450 reductase (CPR) were measured in aortic
266 enzymes that rely on the same protein, NADPH-cytochrome P450 reductase (POR), to provide the electron
268 For the past 40 years, my interest has been cytochrome P450 structure-function and structure-activit
270 eds led to the identification of CYP88A13, a cytochrome P450 that catalyzes the C-16alpha hydroxylati
271 hydroxylase, thiolate-ligated heme-dependent cytochrome P450, and four nonheme oxygenases, namely, te
272 a candidate gene encoding an uncharacterized cytochrome P450, CYP71A27 Loss of this gene resulted in
274 Genome mining enabled identification of the cytochrome P450, NzeB (Streptomyces sp. NRRL F-5053), wh
275 ural evaluation of a reconstructed ancestral cytochrome P450, revealing key features that appear to c
276 gene expansions in the glycosyltransferase, cytochrome P450, shikimate hydroxycinnamoyl transferase,
278 tical review of the evidence for presence of cytochrome P450-mediated metabolic resistance mechanisms
282 been proposed that such chemoresistance via cytochrome P450/drug transporters can be reversed with t
287 ed structure with those of well-investigated cytochromes P450 from mammals and bacteria enabled us to
289 51 enzymes (sterol 14alpha-demethylases) are cytochromes P450 that catalyze multistep reactions.
290 rbicide metabolism-based resistances include cytochromes P450, GSH S-transferases, glucosyl and other
292 production improves subsequent decoration by cytochrome P450s, supporting efficient conversion of (S)
293 is minimized its oxidase activity and b-type cytochrome protein was constructed to realize multiplexe
296 ted diphenyl ethers (PBDEs) and induction of cytochrome's P450 (CYP1A1 and CYP2B isoforms) were evalu
297 ated crystalline lattices of Small Tetraheme Cytochromes (STC) forming well-defined, three-dimensiona
298 enases' substrates through quinones and then cytochromes to O(2), these results imply that the site o
299 en revealed to be facilitated through c-type cytochromes, which mediate charge between the electrode
300 genomic database search revealed that c-type cytochromes with a contracted CXCH heme-binding motif ar